208 related articles for article (PubMed ID: 7855781)
1. Hypercoagulability state in patients with chronic obstructive pulmonary disease. Chronic Obstructive Bronchitis and Haemostasis Group.
Alessandri C; Basili S; Violi F; Ferroni P; Gazzaniga PP; Cordova C
Thromb Haemost; 1994 Sep; 72(3):343-6. PubMed ID: 7855781
[TBL] [Abstract][Full Text] [Related]
2. [Prethrombotic state in patients with chronic obstructive pulmonary disease and treatment with heparin].
Xie M; Wang Z
Hua Xi Yi Ke Da Xue Xue Bao; 1998 Dec; 29(4):411-4. PubMed ID: 10743240
[TBL] [Abstract][Full Text] [Related]
3. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
Koga S
Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
[TBL] [Abstract][Full Text] [Related]
4. Nonvalvular atrial fibrillation: evidence for a prothrombotic state.
Kahn SR; Solymoss S; Flegel KM
CMAJ; 1997 Sep; 157(6):673-81. PubMed ID: 9307553
[TBL] [Abstract][Full Text] [Related]
5. The effect of prophylactic heparin treatment on enhanced thrombin generation in pregnancy.
Bremme K; Lind H; Blombäck M
Obstet Gynecol; 1993 Jan; 81(1):78-83. PubMed ID: 8416465
[TBL] [Abstract][Full Text] [Related]
6. Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels.
Wedzicha JA; Seemungal TA; MacCallum PK; Paul EA; Donaldson GC; Bhowmik A; Jeffries DJ; Meade TW
Thromb Haemost; 2000 Aug; 84(2):210-5. PubMed ID: 10959691
[TBL] [Abstract][Full Text] [Related]
7. Coagulation and fibrinolytic markers in a two-month follow-up of coronary bypass surgery.
Parolari A; Colli S; Mussoni L; Eligini S; Naliato M; Wang X; Gandini S; Tremoli E; Biglioli P; Alamanni F
J Thorac Cardiovasc Surg; 2003 Feb; 125(2):336-43. PubMed ID: 12579103
[TBL] [Abstract][Full Text] [Related]
8. Correlation between tumor necrosis factor-alpha and D-dimer levels in non-small cell lung cancer patients.
Guadagni F; Ferroni P; Basili S; Facciolo F; Carlini S; Crecco M; Martini F; Spila A; D'Alessandro R; Aloe S; Cerasoli V; Del Monte G; Mariotti S; Mineo TC; Roselli M
Lung Cancer; 2004 Jun; 44(3):303-10. PubMed ID: 15140543
[TBL] [Abstract][Full Text] [Related]
9. [The significance of maximal expiratory concentrations of CO2 (MEC CO2) in the negative diagnosis of acute pulmonary embolism in chronic obstructive bronchopneumopathies].
Grosbois JM; Bart F; Douay B; Fortin F; Dernis JM; Wallaert B
Rev Mal Respir; 1995; 12(1):35-41. PubMed ID: 7899665
[TBL] [Abstract][Full Text] [Related]
10. Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease.
Valipour A; Schreder M; Wolzt M; Saliba S; Kapiotis S; Eickhoff P; Burghuber OC
Clin Sci (Lond); 2008 Oct; 115(7):225-32. PubMed ID: 18307413
[TBL] [Abstract][Full Text] [Related]
11. Periodontitis is characterized by elevated PAI-1 activity.
Bizzarro S; van der Velden U; ten Heggeler JM; Leivadaros E; Hoek FJ; Gerdes VE; Bakker SJ; Gans RO; Ten Cate H; Loos BG
J Clin Periodontol; 2007 Jul; 34(7):574-80. PubMed ID: 17535288
[TBL] [Abstract][Full Text] [Related]
12. Haemostatic and lipid determinants of prothrombin fragment F1.2 and D-dimer in plasma.
MacCallum PK; Cooper JA; Martin J; Howarth DJ; Meade TW; Miller GJ
Thromb Haemost; 2000 Mar; 83(3):421-6. PubMed ID: 10744148
[TBL] [Abstract][Full Text] [Related]
13. Influence of long term oral anticoagulants upon prothrombin fragment 1 + 2, thrombin-antithrombin III complex and D-Dimer levels in patients affected by proximal deep vein thrombosis.
Elias A; Bonfils S; Daoud-Elias M; Gauthier B; Sié P; Boccalon H; Boneu B
Thromb Haemost; 1993 Apr; 69(4):302-5. PubMed ID: 8497840
[TBL] [Abstract][Full Text] [Related]
14. TAT, F1 + 2, and D-dimer levels in patients after coronary angiography with nonionic or ionic contrast media or after cardiac catheterization.
Biancardi M; Cimminiello C; Toschi V; Schiavina G; Regalia F; Casolo F; Bonfardeci G
Semin Thromb Hemost; 1996; 22 Suppl 1():61-5. PubMed ID: 8807731
[TBL] [Abstract][Full Text] [Related]
15. Clinical utility of prothrombin fragment 1+2, thrombin antithrombin III complexes and D-dimer measurements in the diagnosis of deep vein thrombosis following total hip replacement.
Cofrancesco E; Cortellaro M; Corradi A; Ravasi F; Bertocchi F
Thromb Haemost; 1998 Mar; 79(3):509-10. PubMed ID: 9531030
[TBL] [Abstract][Full Text] [Related]
16. Studies on the physiopathology of chronic obstructive pulmonary disease in the horse. IV. Blood gas and acid-base values at rest.
Littlejohn A; Bowles F
Onderstepoort J Vet Res; 1981 Mar; 48(1):37-45. PubMed ID: 6792580
[TBL] [Abstract][Full Text] [Related]
17. Activation of the tissue factor pathway of blood coagulation in patients with chronic urticaria.
Asero R; Tedeschi A; Coppola R; Griffini S; Paparella P; Riboldi P; Marzano AV; Fanoni D; Cugno M
J Allergy Clin Immunol; 2007 Mar; 119(3):705-10. PubMed ID: 17204316
[TBL] [Abstract][Full Text] [Related]
18. Fibrin clot properties are altered in patients with chronic obstructive pulmonary disease. Beneficial effects of simvastatin treatment.
Undas A; Kaczmarek P; Sladek K; Stepien E; Skucha W; Rzeszutko M; Gorkiewicz-Kot I; Tracz W
Thromb Haemost; 2009 Dec; 102(6):1176-82. PubMed ID: 19967149
[TBL] [Abstract][Full Text] [Related]
19. Elevated levels of prothrombin fragment 1 + 2 indicate high risk of thrombosis.
Ota S; Wada H; Abe Y; Yamada E; Sakaguchi A; Nishioka J; Hatada T; Ishikura K; Yamada N; Sudo A; Uchida A; Nobori T
Clin Appl Thromb Hemost; 2008 Jul; 14(3):279-85. PubMed ID: 18160575
[TBL] [Abstract][Full Text] [Related]
20. CD40 ligand enhances monocyte tissue factor expression and thrombin generation via oxidative stress in patients with hypercholesterolemia.
Sanguigni V; Ferro D; Pignatelli P; Del Ben M; Nadia T; Saliola M; Sorge R; Violi F
J Am Coll Cardiol; 2005 Jan; 45(1):35-42. PubMed ID: 15629370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
